Gail S. Wright
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 5
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 1
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Hope S. Rugo (3 shared papers)Seock‐Ah Im (2 shared papers)Carlos H. Barrios (1 shared paper)Amreen Husain (1 shared paper)Véronique Dièras (1 shared paper)Leisha A. Emens (1 shared paper)Sylvia Adams (1 shared paper)Volkmar Henschel (1 shared paper)
- Journals
- Gynecologic Oncology (4 papers)Cancer Research (4 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)npj Breast Cancer (1 paper)
- Partner nations
- United StatesSerbiaCroatia
In The Last Decade
Gail S. Wright
17 papers receiving 3.7k citations
Gail S. Wright's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 2.3k
- Cancer Research 590
- Immunology 799
- Pulmonary and Respiratory Medicine 830
- Genetics 95
Countries citing papers authored by Gail S. Wright
This map shows the geographic impact of Gail S. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail S. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail S. Wright more than expected).
Fields of papers citing papers by Gail S. Wright
This network shows the impact of papers produced by Gail S. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail S. Wright. The network helps show where Gail S. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Gail S. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer Hit paper breakdown → | 2018 | 3127 |
| 2 | 2009 | 142 | |
| 3 | 2013 | 94 | |
| 4 | 2019 | 92 | |
| 5 | 2022 | 47 | |
| 6 | 2010 | 42 | |
| 7 | 2021 | 42 | |
| 8 | 2000 | 36 | |
| 9 | 2018 | 35 | |
| 10 | 2021 | 31 | |
| 11 | 2013 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2018 | 3 | |
| 17 | 2025 | 1 | |
| 18 | 2019 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2022 | 0 |
About Gail S. Wright
Gail S. Wright is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Reproductive Medicine, having authored 20 papers that have together received 3.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers), PARP inhibition in cancer therapy (4 papers), Cancer Genomics and Diagnostics (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (590 citations), Immunology (799 citations), Pulmonary and Respiratory Medicine (830 citations) and Genetics (95 citations). Gail S. Wright has collaborated with scholars based in United States, Serbia and Croatia. Frequent co-authors include Hope S. Rugo, Seock‐Ah Im, Carlos H. Barrios, Amreen Husain, Véronique Dièras, Leisha A. Emens, Sylvia Adams, Volkmar Henschel, Roel Funke and Hiroji Iwata. Their work appears in journals such as Gynecologic Oncology, Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.